NYSE:RYAN Ryan Specialty (RYAN) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free RYAN Stock Alerts $48.94 -0.88 (-1.77%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$48.48▼$49.5150-Day Range$45.74▼$56.0052-Week Range$39.44▼$56.51Volume997,947 shsAverage Volume792,696 shsMarket Capitalization$12.74 billionP/E Ratio95.96Dividend Yield0.90%Price Target$54.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Ryan Specialty alerts: Email Address Ryan Specialty MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside10.9% Upside$54.25 Price TargetShort InterestBearish6.91% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.32Based on 11 Articles This WeekInsider TradingN/AProj. Earnings Growth20.34%From $1.77 to $2.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.99 out of 5 starsFinance Sector520th out of 848 stocksInsurance Agents, Brokers, & Service Industry12th out of 18 stocks 3.2 Analyst's Opinion Consensus RatingRyan Specialty has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 4 buy ratings, 4 hold ratings, and 1 sell rating.Amount of Analyst CoverageRyan Specialty has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.91% of the float of Ryan Specialty has been sold short.Short Interest Ratio / Days to CoverRyan Specialty has a short interest ratio ("days to cover") of 8.7.Change versus previous monthShort interest in Ryan Specialty has recently increased by 11.09%, indicating that investor sentiment is decreasing significantly. Previous Next 0.8 Dividend Strength Dividend YieldRyan Specialty has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthRyan Specialty does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Ryan Specialty is 86.27%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Ryan Specialty will have a dividend payout ratio of 20.66% next year. This indicates that Ryan Specialty will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RYAN. Previous Next 1.8 News and Social Media Coverage News SentimentRyan Specialty has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Ryan Specialty this week, compared to 6 articles on an average week.MarketBeat FollowsOnly 2 people have added Ryan Specialty to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ryan Specialty insiders have not sold or bought any company stock.Percentage Held by Insiders11.10% of the stock of Ryan Specialty is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.82% of the stock of Ryan Specialty is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Ryan Specialty are expected to grow by 20.34% in the coming year, from $1.77 to $2.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ryan Specialty is 95.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 141.29.Price to Earnings Ratio vs. SectorThe P/E ratio of Ryan Specialty is 95.96, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 52.71.Price to Book Value per Share RatioRyan Specialty has a P/B Ratio of 13.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Ryan Specialty Stock (NYSE:RYAN)Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.Read More RYAN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RYAN Stock News HeadlinesApril 26, 2024 | msn.comA Look at Tennessee's Farm-Themed License PlateApril 26, 2024 | finance.yahoo.comQ1 2024 Piper Sandler Companies Earnings CallApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 26, 2024 | msn.comTennessee regulations prevent good addiction treatment for opioid use disorder patientsApril 25, 2024 | bizjournals.comFretboard Brewing to open fourth locationApril 25, 2024 | msn.comCT supermarket reopens with high-tech carts, Munson’s chocolates, expanded grab-and-go, fresh specialty popcornApril 25, 2024 | americanbankingnews.comRyan Specialty (RYAN) to Release Quarterly Earnings on ThursdayApril 24, 2024 | yahoo.comI went through fertility treatments for 10 years, and I'd do it all over againApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 24, 2024 | markets.businessinsider.comBuy Rating on LKQ: Brinkman Optimistic Despite Short-Term HeadwindsApril 24, 2024 | msn.comIt took me 10 years of fertility treatments to have 2 kids. I’d do it all againApril 23, 2024 | nypost.comRyan Garcia stuns Devin Haney after bizarre week: ‘Thought I was crazy?’April 18, 2024 | americanbankingnews.comRyan Specialty Holdings, Inc. (NYSE:RYAN) Receives Consensus Rating of "Hold" from AnalystsApril 16, 2024 | msn.comParamount Completes Exec Shuffle Atop Sports Ad Sales Group, With Ryan Briganti Succeeding Retiring John BoguszApril 11, 2024 | msn.comUofL opens new one-stop shop specialty clinic downtownApril 7, 2024 | finance.yahoo.comCoffee Hound Junction Brings Specialty Coffee with Hometown Flair to Bentonville, Arkansas with Support from Crimson Cup Coffee & TeaApril 7, 2024 | msn.comThe History and Pride Behind Mississippi's Farm-Themed Specialty License PlateApril 4, 2024 | sports.yahoo.comWhat’s Opening Day in St. Louis without pep rallies, chilling winds and more injuries?April 4, 2024 | msn.comJames Comer pushed to investigate Trump's media company for 'influence peddling'April 4, 2024 | msn.comNY uses obscure civil-practice law to demand a closer look at Trump's $175M appeal bond — and at its underwriter, Knight SpecialtyApril 4, 2024 | businesswire.comRyan Specialty to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024April 3, 2024 | sports.yahoo.comBoys track and field: Who to watch for as 2024 season kicks into gearApril 3, 2024 | bizjournals.comOrlando Health debuts new institute to bring specialty service downtownApril 1, 2024 | msn.comDragon’s Dogma 2 Review (PS5): Another Trial By FireApril 1, 2024 | msn.comThese 23 comedy movies on Netflix will bring the belly laughsMarch 29, 2024 | msn.comAugusta National unveiled *exactly* how to make its famous Azalea cocktailMarch 29, 2024 | msn.comEmpathic Podiatry adopts eClinicalWorks cloud EHR systemSee More Headlines Receive RYAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ryan Specialty and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Ex-Dividend for 3/27 Dividend3/12/2024Dividend Payable3/27/2024Today4/26/2024Next Earnings (Confirmed)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Insurance agents, brokers, & service Sub-IndustryN/A Current SymbolNYSE:RYAN CUSIPN/A CIK1849253 Webryansg.com Phone312-784-6001FaxN/AEmployees4,350Year FoundedN/APrice Target and Rating Average Stock Price Target$54.25 High Stock Price Target$62.00 Low Stock Price Target$49.00 Potential Upside/Downside+10.9%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$0.51 Trailing P/E Ratio95.96 Forward P/E Ratio27.65 P/E GrowthN/ANet Income$61.04 million Net Margins9.36% Pretax Margin11.45% Return on Equity44.84% Return on Assets6.18% Debt Debt-to-Equity Ratio1.98 Current Ratio1.16 Quick Ratio1.16 Sales & Book Value Annual Sales$2.08 billion Price / Sales6.13 Cash Flow$2.41 per share Price / Cash Flow20.30 Book Value$3.76 per share Price / Book13.02Miscellaneous Outstanding Shares260,220,000Free Float231,339,000Market Cap$12.74 billion OptionableOptionable Beta0.52 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Timothy William Turner (Age 63)President & Director Comp: $3.95MMr. Jeremiah Rawlins Bickham (Age 38)Executive VP & CFO Comp: $1.64MMr. Mark Stephen Katz Esq. (Age 55)Executive VP, General Counsel & Corporate Secretary Comp: $1.57MMr. Brendan Martin Mulshine (Age 58)Executive VP & Chief Revenue Officer Comp: $1.8MMr. Patrick G. Ryan (Age 86)Chairman & CEO Comp: $4.48MMr. Kirk A. BehrensExecutive Vice President of Operations, Technology & Data AnalyticsMs. Janice M. HamiltonSenior VP, Controller & Chief Accounting OfficerMr. Bradley Eames Bodell B.S. (Age 58)Chief Information Officer Mr. Mark C. MelanderChief Administrative OfficerMr. Nicholas J. Mezick C.F.A.Director of Investor RelationsMore ExecutivesKey CompetitorsEquitableNYSE:EQHErie IndemnityNASDAQ:ERIEEnactNASDAQ:ACTBrown & BrownNYSE:BROWillis Towers Watson PublicNASDAQ:WTWView All CompetitorsInsiders & InstitutionsPeregrine Capital Management LLCSold 12,360 shares on 4/26/2024Ownership: 0.097%SYSTM Wealth Solutions LLCBought 20,809 shares on 4/26/2024Ownership: 0.027%Bar Harbor Wealth ManagementBought 63,214 shares on 4/24/2024Ownership: 0.024%KLR Investment Advisors LLCSold 584 shares on 4/23/2024Ownership: 0.004%Maryland State Retirement & Pension SystemBought 1,227 shares on 4/20/2024Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions RYAN Stock Analysis - Frequently Asked Questions Should I buy or sell Ryan Specialty stock right now? 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ryan Specialty in the last year. There are currently 1 sell rating, 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RYAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYAN, but not buy additional shares or sell existing shares. View RYAN analyst ratings or view top-rated stocks. What is Ryan Specialty's stock price target for 2024? 9 Wall Street analysts have issued 12 month target prices for Ryan Specialty's stock. Their RYAN share price targets range from $49.00 to $62.00. On average, they predict the company's stock price to reach $54.25 in the next twelve months. This suggests a possible upside of 10.9% from the stock's current price. View analysts price targets for RYAN or view top-rated stocks among Wall Street analysts. How have RYAN shares performed in 2024? Ryan Specialty's stock was trading at $43.02 at the beginning of 2024. Since then, RYAN shares have increased by 13.8% and is now trading at $48.94. View the best growth stocks for 2024 here. When is Ryan Specialty's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our RYAN earnings forecast. How can I listen to Ryan Specialty's earnings call? Ryan Specialty will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Ryan Specialty's earnings last quarter? Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced its earnings results on Tuesday, February, 27th. The company reported $0.35 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.35. The business earned $532.90 million during the quarter, compared to the consensus estimate of $524.08 million. Ryan Specialty had a trailing twelve-month return on equity of 44.84% and a net margin of 9.36%. The firm's revenue was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.27 earnings per share. How often does Ryan Specialty pay dividends? What is the dividend yield for Ryan Specialty? Ryan Specialty declared a None dividend on Tuesday, February 27th. Shareholders of record on Wednesday, March 13th will be given a dividend of $0.34 per share on Wednesday, March 27th. The ex-dividend date is Tuesday, March 12th. Read our dividend analysis for RYAN. Is Ryan Specialty a good dividend stock? Ryan Specialty (NYSE:RYAN) pays an annual dividend of $0.44 per share and currently has a dividend yield of 0.86%. The dividend payout ratio is 86.27%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, RYAN will have a dividend payout ratio of 20.66% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for RYAN. What ETFs hold Ryan Specialty's stock? ETFs with the largest weight of Ryan Specialty (NYSE:RYAN) stock in their portfolio include SPDR S&P Insurance ETF (KIE), Renaissance IPO ETF (IPO), First Trust Financial AlphaDEX Fund (FXO), Invesco Dorsey Wright Financial Momentum ETF (PFI), Zacks Small/Mid Cap Core Portfolio ETF (SMIZ), First Trust Multi-Manager Small Cap Opportunities ETF (MMSC), Nuveen ESG Small-Cap ETF (NUSC) and First Trust US Equity Opportunities ETF (FPX). When did Ryan Specialty IPO? Ryan Specialty (RYAN) raised $1.3 billion in an IPO on Thursday, July 22nd 2021. The company issued 56,918,278 shares at a price of $22.00-$25.00 per share. Who are Ryan Specialty's major shareholders? Ryan Specialty's stock is owned by many different retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.56%), Norden Group LLC (0.30%), Dudley & Shanley Inc. (0.18%), Peregrine Capital Management LLC (0.10%), SYSTM Wealth Solutions LLC (0.03%) and Renaissance Capital LLC (0.02%). Insiders that own company stock include Brendan Martin Mulshine, Corp Onex, David P Bolger, Lisa Jo Paschal-Alcorn, Mark Stephen Katz, Michael D Ohalleran, Michael Thomas Vanacker, Nicholas Dominic Cortezi, Patrick G Ryan and Timothy William Turner. View institutional ownership trends. How do I buy shares of Ryan Specialty? Shares of RYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RYAN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ryan Specialty Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
